NLS Agreement

Orion Corporation and Propeller Health, a digital therapeutics company, have announced a partnership to connect the Easyhaler line of inhalers for asthma and COPD to Propeller’s digital medicine platform. The partnership will expand Propeller’s presence in Europe, where Orion serves patients across several countries. Propeller’s platform currently covers more than 90 percent of inhaled medicines for asthma […]

Dignitana has partnered with ThermoTek to develop the DigniCap Delta, a model of the 2015 FDA-cleared DigniCap Scalp Cooling System. The new model is featuring a new single-patient use cap design and a smaller, more streamlined single-patient machine, reports the company. U.S. Food and Drug Adminstration clearance for the new device is anticipated in spring 2019. […]

The two companies have announced that they have entered into an exclusive collaboration to develop the OnDosis’ technology for prescription medicines in all pain related indications. The agreement also entails an option for Grünenthal to an exclusive worldwide license to the technology in these indications. First partnering deal The agreement is the first partnering deal […]

The company reports that a collaboration agreement with the Centre for Skin Sciences (CSS) at University of Bradford, UK, has been signed. The aim is to combine in vitro experiments with the use of bioinformatics data mining and analysis to investigate the mode of action of Follicum’s different peptide classes using an in silico approach (big data analysis). The […]

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market. The objective is to develop an improved treatment for both the patient and for healthcare professionals. The new treatment for the management of ADHD […]

Orion Corporation and Novartis Pharma have agreed that Novartis will return the sales and distribution rights in certain European countries for Parkinson’s disease drug Stalevo to Orion. The sales and distribution rights in certain European countries for the proprietary product Stalevo (active pharmaceutical ingredients: levodopa, carbidopa, entacapone), which has been patented and developed by Orion […]